Recent research suggests that genetic variation in AKT1 is involved in the cognitive effects of cannabis on psychosis (ref. 39n = 611) and on the acute psychotomimetic effects of smoked cannabis (ref. 29n = 442) as assessed by the Psychotomimetic States Inventory (PSI; ref. 8). This evidence concerns the gene AKT1 and psychotic disorder.